阿特拉斯黄连木种子油与卡诺拉油调和油对比含合成抗氧化剂及不含合成抗氧化剂的玉米-卡诺拉调和油对代谢综合征患者氧化应激标志物影响的试验方案:三盲随机三向交叉临床试验
该方案计划在72例代谢综合征患者中开展单中心、三盲、三向随机交叉临床试验,比较阿特拉斯黄连木种子-卡诺拉调和油、含TBHQ的玉米-卡诺拉调和油及不含TBHQ的玉米-卡诺拉调和油对氧化应激标志物的影响。每种干预油食用8周,间隔4周洗脱期,主要结局为血清总抗氧化能力等氧化应激标志物。
要点
- 三盲、三向交叉设计比较三种调和油对代谢综合征患者氧化应激标志物的影响。
- 主要结局包括血清总抗氧化能力、总氧化状态、丙二醛、一氧化氮及多种抗氧化酶活性。
- 次要结局为代谢综合征组分变化,包括血压、空腹血糖、甘油三酯、高密度脂蛋白胆固醇及人体测量指标。
核心结论
- 阿特拉斯黄连木种子油富含抗氧化剂,该干预可能为代谢综合征患者提供氧化应激预防的一种选择。
- 本临床试验将是首个评估阿特拉斯黄连木油对人体氧化应激标志物影响的试验。
研究设计与样本
- 单中心、三盲、三向随机交叉临床试验(RCT),纳入72例代谢综合征患者。
- 经过1个月导入期后,合格参与者按随机顺序将干预油作为日常食用油食用。
- 每个干预期持续8周,期间间隔4周洗脱期。
- 在每个干预期开始和结束时评估人体测量指标、体成分、体力活动、血压及24小时膳食回顾。
主要发现
- 该方案为试验设计描述,尚未报告干预效果数据。
关键数值与推荐
- 主要结局为氧化应激标志物,包括血清总抗氧化能力、总氧化状态、丙二醛、一氧化氮,以及髓过氧化物酶、超氧化物歧化酶、过氧化氢酶、谷胱甘肽过氧化物酶和谷胱甘肽还原酶的酶活性。
- 次要结局为代谢综合征组分变化,包括血压、空腹血糖、甘油三酯、高密度脂蛋白胆固醇及人体测量指标。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Metabolic syndrome (MetS) is regarded as a complex metabolic disorder. Recently, the role of dietary antioxidants in the underlying pathogenesis and complications of MetS has come into focus. Pistacia atlantica oil is known as a high antioxidant oil which might improve the antioxidant status of dietary oils and also oxidative stress markers. On the other hand, tert-Butylhydroquinone (TBHQ) is an approved food-grade synthetic antioxidant that acts both as an inducer and inhibitor of carcinogenesis. The current trial will explore the possible effect of a blend of Pistacia atlantica seed-canola oils, corn-canola oils with TBHQ, and corn-canola oil without TBHQ on oxidative stress markers in patients with MetS. METHODS: We will conduct a single-center, triple-blind, three-way randomized cross-over clinical trial (RCT) among 72 patients with MetS. After a 1-month run-in period, eligible participants will consume the intervention oils as their regularly consumed oils in a random order. Each intervention period will last 8 weeks separated by 4-week washout periods. Anthropometric indices, body composition, physical activity, blood pressure, and 24-h dietary food recall measurements will be assessed at the beginning and the end of each intervention period. The primary outcome will be oxidative stress markers including serum total antioxidant capacity, total oxidant status, malondialdehyde, nitric oxide, and the enzyme activity of myeloperoxidase, superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase. The secondary outcomes will be changes in MetS components including blood pressure, fasting blood glucose, triglyceride, high-density lipoprotein cholesterol, and anthropometric measurements. DISCUSSION: Pistacia atlantica seed oil is high in antioxidants. An intervention with this oil could offer an option for oxidative stress prevention among patients with metabolic syndrome. The present clinical trial will be the first one assessing the impact of Pistacia atlantica oil on human oxidative stress markers. TRIAL REGISTRATION: Iranian Registry of Clinical trials IRCT20130223012571N8 . Registered on 4 March 2022.
引用
- Sasanfar B, Emrani AS, Zademohammadi F, et al. The impact of a blend of Pistacia atlantica seed and canola oil compared with a blend of corn-canola oil with synthetic antioxidant and corn-canola oil without synthetic antioxidant on oxidative stress markers in patients with metabolic syndrome: protocol for a triple-blind, randomized, three-way cross-over clinical trial. Trials. 2023. PMID: 37488571. doi:10.1186/s13063-023-07269-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。